Update on regulatory review of lecanemab for treatment of early Alzheimer's disease in the European Union
BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced that the European Commission has asked the Committee ...
Drug Discovery Services Market Dynamics, Growth, And Opportunities By Exactitude Consultancy
The drug discovery services market is expanding, driven by advancements in biotechnology, personalized medicine, and the increasing demand for efficient, cost-effective drug development solutions.” - ...